SCHEMBL10744792

SCHEMBL10744792

S=c1c2ccccc2[se]n1-c1nnc2cc(Cl)ccc2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CG P48736 1/20 0.40
▸ METAP2 P50579 2/20 0.38
▸ ALDH1A1 P00352 3/20 0.33
▸ KDM4E B2RXH2 3/20 0.33
▸ NPSR1 Q6W5P4 3/20 0.33
▸ MAPT P10636 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ LMNA P02545 2/20 0.33
▸ GLA P06280 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ AHR P35869 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ USP2 O75604 1/20 0.32
▸ CASP1 P29466 1/20 0.32
▸ CASP7 P55210 1/20 0.32
▸ S1PR2 O95136 1/20 0.32
▸ KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10748283 0.85 METAP2 (0.36) METAP2ALDH1A1KDM4ENPSR1MAPT
SCHEMBL10749509 0.85 METAP2 (0.51) METAP2ALDH1A1KDM4ENPSR1MAPT
SCHEMBL10747393 0.85 METAP2 (0.39) METAP2ALDH1A1KDM4ENPSR1MAPT
SCHEMBL10746433 0.80 KMT2A (0.38) ALDH1A1MAPTSMN1; SMN2LMNAKMT2A
SCHEMBL10747007 0.75 METAP2 (0.38) METAP2ALDH1A1KDM4ENPSR1MAPT
SCHEMBL10746662 0.72 METAP2 (0.38) METAP2ALDH1A1KDM4ENPSR1MAPT
SCHEMBL10501643 0.71 METAP2 (0.46) METAP2ALDH1A1KDM4ENPSR1MAPT
SCHEMBL10501842 0.71 METAP2 (0.49) METAP2ALDH1A1KDM4ENPSR1MAPT
SCHEMBL10501413 0.70 MPI (0.51) METAP2ALDH1A1LMNAUSP2
SCHEMBL10501411 0.70 METAP2 (0.38) METAP2ALDH1A1KDM4ENPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback